Inactive Instrument

Analyst Reco. ChemoCentryx, Inc.

Equities

CCXI

US16383L1061

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

Stifel Cuts ChemoCentryx to Hold From Buy, Price Target to $52 From $86	10/22/10	MT
SVB Securities Downgrades ChemoCentryx to Market Perform From Outperform, Adjusts Price Target to $52 From $64	05/22/05	MT
HC Wainwright Downgrades ChemoCentryx to Neutral From Buy, Adjusts Price Target to $52 From $101	05/22/05	MT
Canaccord Genuity Downgrades ChemoCentryx to Hold From Buy; Price Target is $52	05/22/05	MT
Raymond James Downgrades ChemoCentryx to Market Perform From Strong Buy	05/22/05	MT
Wells Fargo Downgrades ChemoCentryx to Equalweight From Overweight, Lowers Price Target to $52 From $62	05/22/05	MT
Piper Sandler Downgrades ChemoCentryx to Neutral From Overweight, Keeps $52 Price Target	04/22/04	MT
Canaccord Genuity Assumes ChemoCentryx at Buy with $81 Price Target	04/22/04	MT
Raymond James Adjusts Price Target on ChemoCentryx to $110 From $107, Maintains Strong Buy Rating	10/21/10	MT
CHEMOCENTRYX : SVB Leerink Upgrades ChemoCentryx to Outperform From Market Perform, Adjusts Price Target to $64 From $17	11/21/11	MT
CHEMOCENTRYX : JPMorgan Upgrades ChemoCentryx to Neutral from Underweight, Adjusts Price Target to $38 from $14	11/21/11	MT
CHEMOCENTRYX : Raymond James Upgrades ChemoCentryx to Strong Buy From Outperform, Boosts Price Target to $107 From $62	11/21/11	MT
CHEMOCENTRYX : Canaccord Genuity Adjusts Price Target on ChemoCentryx to $64 From $79, Reiterates Buy Rating	11/21/11	MT
CHEMOCENTRYX : Stifel Lifts ChemoCentryx to Buy From Hold, Price Target to $31 From $26	07/21/07	MT
CHEMOCENTRYX : Piper Sandler Downgrades ChemoCentryx to Neutral From Overweight; Price Target is $25	07/21/07	MT
CHEMOCENTRYX : JPMorgan Cuts ChemoCentryx to Underweight From Neutral, Price Target to $17 From $57	07/21/07	MT
CHEMOCENTRYX : HC Wainwright Adjusts Price Target on ChemoCentryx to $28 From $101, Maintains Buy Rating	07/21/07	MT
CHEMOCENTRYX : SVB Leerink Downgrades ChemoCentryx to Market Perform From Outperform; Price Target is $17	07/21/07	MT
CHEMOCENTRYX : Raymond James Cuts ChemoCentryx to Outperform From Strong Buy, Price Target to $51 From $120	07/21/07	MT
CHEMOCENTRYX : Stifel Downgrades ChemoCentryx to Hold From Buy, Adjusts Price Target to $26 From $93	07/21/07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. ChemoCentryx, Inc.

Equities

CCXI

US16383L1061

Analyst Reco.

Filters